Log In
BCIQ
Print this Print this
 

Triage CardioProfiler Panel

  Manage Alerts
Collapse Summary General Information
Company Alere Inc.
DescriptionImmunoassay which measures all four (Troponin I, CK-MB, myoglobin, and BNP) cardiac markers in whole blood and plasma
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCardiovascular, Diagnostic
Indication DetailsDiagnose acute myocardial infarction (AMI); Diagnose congestive heart failure (CHF)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$8,400.0M

$5,800.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/01/2016

$8,400.0M

$5,800.0M

0

Get a free BioCentury trial today